Bluejay Diagnostics, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
Frances Scally, who had served as the Company’s Interim Chief Financial Officer pursuant to such agreements with DLA, ceased serving as an officer of the Company.
the Board of Directors of the Company (the “Board”) has designated Neil Dey, the Company’s President and Chief Executive Officer, as the Company’s the principal financial and accounting officer, in addition to serving as principal executive officer.
Extracted from this filing and checked against the source text.
Frances Scally departed as Interim Chief Financial Officer at Bluejay Diagnostics, Inc..
Frances Scally, who had served as the Company’s Interim Chief Financial Officer pursuant to such agreements with DLA, ceased serving as an officer of the Company.View on SEC.gov
Neil Dey changed role as President and Chief Executive Officer (designated as principal financial and accounting officer) at Bluejay Diagnostics, Inc..
the Board of Directors of the Company (the “Board”) has designated Neil Dey, the Company’s President and Chief Executive Officer, as the Company’s the principal financial and accounting officer, in addition to serving as principal executive officer.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.